HEADER TRANSCRIPTION 14-DEC-11 3V49 TITLE STRUCTURE OF AR LBD WITH ACTIVATOR PEPTIDE AND SARM INHIBITOR 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANDROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 654-919; COMPND 5 SYNONYM: DIHYDROTESTOSTERONE RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 6 GROUP C MEMBER 4; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ANDROGEN RECEPTOR, ACTIVATOR PEPTIDE; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: UNP RESIDUES 21-31; COMPND 12 SYNONYM: DIHYDROTESTOSTERONE RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 13 GROUP C MEMBER 4; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AR, DHTR, NR3C4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS DIARYLHYDANTOIN, SYNTHESIS, SARM, ANTIANDROGEN, LIGAND BINDING KEYWDS 2 DOMAIN, TESTOSTERONE, DIHYDROTESTOSTERONE, TRANSCRIPTION, SARM KEYWDS 3 (SELECTIVE ANDROGEN RECEPTOR MODULATOR) EXPDTA X-RAY DIFFRACTION AUTHOR F.NIQUE,S.HEBBE,C.PEIXOTO,D.ANNOOT,J.-M.LEFRANCOIS,E.DUVAL,L.MICHOUX, AUTHOR 2 N.TRIBALLEAU,J.-M.LEMOULLEC,P.MOLLAT,M.THAUVIN,T.PRANGE,D.MINET, AUTHOR 3 P.CLEMENT-LACROIX,C.ROBIN-JAGERSCHMIDT,D.FLEURY,D.GUEDIN,P.DEPREZ REVDAT 6 13-SEP-23 3V49 1 REMARK REVDAT 5 24-JAN-18 3V49 1 AUTHOR REVDAT 4 31-AUG-16 3V49 1 REMARK REVDAT 3 08-OCT-14 3V49 1 AUTHOR REVDAT 2 19-DEC-12 3V49 1 JRNL REVDAT 1 05-SEP-12 3V49 0 JRNL AUTH F.NIQUE,S.HEBBE,C.PEIXOTO,D.ANNOOT,J.-M.LEFRANCOIS,E.DUVAL, JRNL AUTH 2 L.MICHOUX,N.TRIBALLEAU,J.M.LEMOULLEC,P.MOLLAT,M.THAUVIN, JRNL AUTH 3 T.PRANGE,D.MINET,P.CLEMENT-LACROIX,C.ROBIN-JAGERSCHMIDT, JRNL AUTH 4 D.FLEURY,D.GUEDIN,P.DEPREZ JRNL TITL DISCOVERY OF DIARYLHYDANTOINS AS NEW SELECTIVE ANDROGEN JRNL TITL 2 RECEPTOR MODULATORS. JRNL REF J.MED.CHEM. V. 55 8225 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22897611 JRNL DOI 10.1021/JM300249M REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.193 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.185 REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 28377 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.191 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 27349 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2084 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 238 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2362.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 7 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 9595 REMARK 3 NUMBER OF RESTRAINTS : 8954 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 ANGLE DISTANCES (A) : 0.033 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.025 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.085 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.046 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.023 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.071 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3V49 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-DEC-11. REMARK 100 THE DEPOSITION ID IS D_1000069575. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-07; 10-JAN-08 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; NULL REMARK 200 RADIATION SOURCE : ESRF; NULL REMARK 200 BEAMLINE : BM30A; NULL REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.934; NULL REMARK 200 MONOCHROMATOR : SI(111); NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; NULL REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28211 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 34.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.18500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: PDB ENTRY 2AMA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP SET UP AS A 50:50 MIXTURE REMARK 280 OF 1 MICROL PROTEIN+1 MICROL RESERVOIR WITH: A) PROTEIN SOLUTION REMARK 280 = 80 MICROL HAR LBD (3.5 MG/ML) + 1.5 MICROL ACTIVATOR REMARK 280 UNDECAPEPTIDE (GAFQNLFQSVR)+1 MICROL LISO4 (0.2 M) IN HEPES REMARK 280 BUFFER 0.1 M + 0.5 MG INHIBITOR 1 (PK0) B) RESERVOIR = 1 ML REMARK 280 HEPES BUFFER 0.1 M + PEG 4000 12-20 %, PH 7.5, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.31450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.90450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.66550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.90450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.31450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.66550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 654 REMARK 465 THR A 655 REMARK 465 THR A 656 REMARK 465 GLN A 657 REMARK 465 LYS A 658 REMARK 465 LEU A 659 REMARK 465 THR A 660 REMARK 465 VAL A 661 REMARK 465 SER A 662 REMARK 465 HIS A 663 REMARK 465 ILE A 664 REMARK 465 GLU A 665 REMARK 465 GLY A 666 REMARK 465 TYR A 667 REMARK 465 GLU A 668 REMARK 465 CYS A 669 REMARK 465 GLN A 670 REMARK 465 LYS A 845 REMARK 465 ARG A 846 REMARK 465 LYS A 847 REMARK 465 ASN A 848 REMARK 465 PRO A 849 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 888 CB SER A 888 OG 0.118 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP A 741 CB - CG - CD2 ANGL. DEV. = 9.2 DEGREES REMARK 500 TRP A 741 CB - CG - CD1 ANGL. DEV. = -8.2 DEGREES REMARK 500 ARG A 774 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG A 871 CD - NE - CZ ANGL. DEV. = 16.9 DEGREES REMARK 500 TYR A 915 CB - CG - CD1 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG B 11 CD - NE - CZ ANGL. DEV. = 11.8 DEGREES REMARK 500 ARG B 11 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 884 -15.29 -38.28 REMARK 500 SER A 884 -101.09 28.03 REMARK 500 HIS A 885 -39.81 -38.11 REMARK 500 SER A 888 28.68 45.47 REMARK 500 SER A 888 80.39 54.57 REMARK 500 ASP A 890 80.23 -39.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PK0 A 950 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF ANDROGEN RECEPTOR, REMARK 800 ACTIVATOR PEPTIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN REMARK 900 IN COMPLEX WITH DIHYDROTESTOSTERONE REMARK 900 RELATED ID: 2Z4J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AR LBD WITH SHP PEPTIDE NR BOX 2 REMARK 900 RELATED ID: 3V4A RELATED DB: PDB DBREF 3V49 A 654 919 UNP P10275 ANDR_HUMAN 654 919 DBREF 3V49 B 1 11 UNP P10275 ANDR_HUMAN 21 31 SEQRES 1 A 266 GLU THR THR GLN LYS LEU THR VAL SER HIS ILE GLU GLY SEQRES 2 A 266 TYR GLU CYS GLN PRO ILE PHE LEU ASN VAL LEU GLU ALA SEQRES 3 A 266 ILE GLU PRO GLY VAL VAL CYS ALA GLY HIS ASP ASN ASN SEQRES 4 A 266 GLN PRO ASP SER PHE ALA ALA LEU LEU SER SER LEU ASN SEQRES 5 A 266 GLU LEU GLY GLU ARG GLN LEU VAL HIS VAL VAL LYS TRP SEQRES 6 A 266 ALA LYS ALA LEU PRO GLY PHE ARG ASN LEU HIS VAL ASP SEQRES 7 A 266 ASP GLN MET ALA VAL ILE GLN TYR SER TRP MET GLY LEU SEQRES 8 A 266 MET VAL PHE ALA MET GLY TRP ARG SER PHE THR ASN VAL SEQRES 9 A 266 ASN SER ARG MET LEU TYR PHE ALA PRO ASP LEU VAL PHE SEQRES 10 A 266 ASN GLU TYR ARG MET HIS LYS SER ARG MET TYR SER GLN SEQRES 11 A 266 CYS VAL ARG MET ARG HIS LEU SER GLN GLU PHE GLY TRP SEQRES 12 A 266 LEU GLN ILE THR PRO GLN GLU PHE LEU CYS MET LYS ALA SEQRES 13 A 266 LEU LEU LEU PHE SER ILE ILE PRO VAL ASP GLY LEU LYS SEQRES 14 A 266 ASN GLN LYS PHE PHE ASP GLU LEU ARG MET ASN TYR ILE SEQRES 15 A 266 LYS GLU LEU ASP ARG ILE ILE ALA CYS LYS ARG LYS ASN SEQRES 16 A 266 PRO THR SER CYS SER ARG ARG PHE TYR GLN LEU THR LYS SEQRES 17 A 266 LEU LEU ASP SER VAL GLN PRO ILE ALA ARG GLU LEU HIS SEQRES 18 A 266 GLN PHE THR PHE ASP LEU LEU ILE LYS SER HIS MET VAL SEQRES 19 A 266 SER VAL ASP PHE PRO GLU MET MET ALA GLU ILE ILE SER SEQRES 20 A 266 VAL GLN VAL PRO LYS ILE LEU SER GLY LYS VAL LYS PRO SEQRES 21 A 266 ILE TYR PHE HIS THR GLN SEQRES 1 B 11 GLY ALA PHE GLN ASN LEU PHE GLN SER VAL ARG HET PK0 A 950 28 HET SO4 A1300 5 HETNAM PK0 4-[(4R)-4-(4-HYDROXYPHENYL)-3,4-DIMETHYL-2,5- HETNAM 2 PK0 DIOXOIMIDAZOLIDIN-1-YL]-2-(TRIFLUOROMETHYL) HETNAM 3 PK0 BENZONITRILE HETNAM SO4 SULFATE ION FORMUL 3 PK0 C19 H14 F3 N3 O3 FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *238(H2 O) HELIX 1 1 PRO A 671 GLU A 681 1 11 HELIX 2 2 SER A 696 ALA A 721 1 26 HELIX 3 3 GLY A 724 LEU A 728 5 5 HELIX 4 4 HIS A 729 ASN A 758 1 30 HELIX 5 5 ASN A 771 SER A 778 1 8 HELIX 6 6 MET A 780 LEU A 797 1 18 HELIX 7 7 THR A 800 PHE A 813 1 14 HELIX 8 8 ASN A 823 CYS A 844 1 22 HELIX 9 9 SER A 851 SER A 888 1 38 HELIX 10 10 PRO A 892 GLN A 902 1 11 HELIX 11 11 GLN A 902 SER A 908 1 7 SHEET 1 A 2 LEU A 762 ALA A 765 0 SHEET 2 A 2 LEU A 768 PHE A 770 -1 O PHE A 770 N LEU A 762 SHEET 1 B 2 ILE A 815 PRO A 817 0 SHEET 2 B 2 VAL A 911 PRO A 913 -1 O LYS A 912 N ILE A 816 SITE 1 AC1 17 LEU A 704 ASN A 705 GLY A 708 TRP A 741 SITE 2 AC1 17 MET A 742 MET A 745 VAL A 746 MET A 749 SITE 3 AC1 17 ARG A 752 PHE A 764 MET A 780 MET A 787 SITE 4 AC1 17 HIS A 874 THR A 877 ILE A 899 VAL A 903 SITE 5 AC1 17 HOH A2007 SITE 1 AC2 5 SER A 696 PHE A 697 LYS A 777 SER A 853 SITE 2 AC2 5 HOH A2073 SITE 1 AC3 18 LYS A 717 LYS A 720 ARG A 726 GLN A 733 SITE 2 AC3 18 MET A 734 GLN A 738 ARG A 871 MET A 894 SITE 3 AC3 18 GLU A 897 LYS A 912 HOH A2081 HOH A2181 SITE 4 AC3 18 HOH B2029 HOH B2107 HOH B2161 HOH B2165 SITE 5 AC3 18 HOH B2227 HOH B2228 CRYST1 54.629 67.331 69.809 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018305 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014852 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014325 0.00000